Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 1.000 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.491 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.455 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.444 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.443 |